Related Experiment Video
Updated: Mar 29, 2026

Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes
Published on: June 28, 2024
Perinatal Phosphatidylcholine Supplementation and Early Childhood Behavior Problems: Evidence for CHRNA7 Moderation
Randal G Ross1, Sharon K Hunter1, M Camille Hoffman1
1From the Departments of Psychiatry, Pediatrics, Cellular and Developmental Biology, and Pharmacology, University of Colorado School of Medicine, Aurora; the Department of Biostatistics and Informatics, University of Colorado School of Public Health, Aurora; and the Departments of Obstetrics and Gynecology and Pediatrics, Denver Health Medical Center, Denver.
High-dose phosphatidylcholine supplementation during pregnancy improved infant cerebral inhibition and reduced childhood behavior problems, potentially mitigating risks for later mental illness.
Area of Science:
- Neuroscience
- Developmental Psychology
- Genetics
Background:
- α7-Nicotinic receptors are crucial for GABA inhibitory synapse maturation before birth.
- Choline, present in amniotic fluid, acts as an agonist at α7-nicotinic receptors.
Purpose of the Study:
- To assess if high-dose oral phosphatidylcholine supplementation during pregnancy enhances fetal cerebral inhibition.
- To determine if this supplementation decreases childhood behavior problems linked to later mental illness.
Main Methods:
- A double-blind, placebo-controlled trial was conducted.
- Parental behavior assessments using the Child Behavior Checklist were performed at 40 months of age.
- Follow-up on previously reported newborn cerebral evoked response suppression.
Main Results:
- Children in the phosphatidylcholine group showed fewer attention problems and less social withdrawal at 40 months.
- Improvements were comparable to deficits associated with later schizophrenia.
- Behavioral outcomes were moderated by CHRNA7 variants and linked to enhanced newborn cerebral inhibition.
Conclusions:
- Maternal phosphatidylcholine treatment may positively influence early behavior development.
- Increased α7-nicotinic acetylcholine receptor activation could alter developmental trajectories for mental illness.
- CHRNA7 gene variants are associated with schizophrenia, autism, and ADHD.
More Related Videos
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Synthesis of Phosphatidylcholine in the ER Membrane
The major components of all eukaryotic cell...
Environmental Influences on Intelligence
Relationship with Parents: Attachment
Conduct Disorder
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.

